SILO PHARMA, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$124.25 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-13
- SILO PHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$178.92K.
- SILO PHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $54.66K.
- SILO PHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$58.16K, a 109.52% decline year-over-year.
- SILO PHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$341.56K.
- SILO PHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $339.27K.
- SILO PHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$53.72K, a 118.46% decline from fiscal 2021.
- SILO PHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was $291.05K, a 301.31% increase from fiscal 2020.
- SILO PHARMA, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $72.53K, a 148.11% increase from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 36 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 39 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$178.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$124.25K 10-Q · filed 2026-08-13 | -$182.41K derived: sum of 3 quarters · filed 2026-08-13 | -$523.97K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $54.66K 10-Q · filed 2026-05-14 | -$3.49K derived: sum of 2 quarters · filed 2026-05-14 | -$345.05K derived: sum of 3 quarters · filed 2026-05-14 | -$468.06K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$58.16K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | -$399.71K derived: sum of 2 quarters · filed 2026-04-14 | -$522.72K derived: sum of 3 quarters · filed 2026-08-13 | -$993.41K POS AM · filed 2026-04-14 | |||
| 2025-09-30 | -$341.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$464.56K derived: sum of 2 quarters · filed 2026-08-13 | -$935.26K 10-Q · filed 2025-11-13 | -$324.09K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$123.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$593.70K 10-Q · filed 2026-08-13 | $17.46K derived: sum of 3 quarters · filed 2026-08-13 | -$260.58K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$470.69K 10-Q · filed 2026-05-14 | $140.47K derived: sum of 2 quarters · filed 2026-05-14 | -$137.57K derived: sum of 3 quarters · filed 2026-05-14 | $64.23K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $611.16K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $333.12K derived: sum of 2 quarters · filed 2026-04-14 | $534.92K derived: sum of 3 quarters · filed 2026-04-14 | $633.01K POS AM · filed 2026-04-14 | |||
| 2024-09-30 | -$278.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$76.24K derived: sum of 2 quarters · filed 2025-11-13 | $21.84K 10-Q · filed 2025-11-13 | $118.66K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $201.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $299.89K 10-Q · filed 2025-08-13 | $396.71K derived: sum of 3 quarters · filed 2025-08-13 | -$44.71K derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $98.08K 10-Q · filed 2025-05-09 | $194.90K derived: sum of 2 quarters · filed 2025-05-09 | -$246.52K derived: sum of 3 quarters · filed 2025-05-09 | $141.29K derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | $96.82K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$344.60K derived: sum of 2 quarters · filed 2025-03-28 | $43.21K derived: sum of 3 quarters · filed 2025-03-28 | $339.27K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | -$441.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$53.61K derived: sum of 2 quarters · filed 2024-11-12 | $242.45K 10-Q · filed 2024-11-12 | $383.02K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $387.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $683.87K 10-Q · filed 2024-08-13 | $824.45K derived: sum of 3 quarters · filed 2024-08-13 | $892.17K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $296.06K 10-Q · filed 2024-05-13 | $296.06K 10-Q · filed 2023-05-12 | $436.63K derived: sum of 2 quarters · filed 2024-05-13 | $504.36K derived: sum of 3 quarters · filed 2024-05-13 | $504.47K derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | $140.57K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $208.29K derived: sum of 2 quarters · filed 2024-03-25 | $208.41K derived: sum of 3 quarters · filed 2024-03-25 | -$53.72K 10-K · filed 2024-03-25 | |||
| 2022-09-30 | $67.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $67.84K derived: sum of 2 quarters · filed 2023-11-13 | -$194.29K 10-Q · filed 2023-11-13 | $12.36K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $117.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$262.01K 10-Q · filed 2023-08-11 | -$55.36K derived: sum of 3 quarters · filed 2023-08-11 | -$36.11K derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | -$262.13K 10-Q · filed 2023-05-12 | -$55.48K derived: sum of 2 quarters · filed 2023-05-12 | -$36.23K derived: sum of 3 quarters · filed 2023-05-12 | -$82.05K derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $206.65K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $225.90K derived: sum of 2 quarters · filed 2023-03-24 | $180.08K derived: sum of 3 quarters · filed 2023-03-24 | $291.05K 10-K · filed 2023-03-24 | |||
| 2021-09-30 | $19.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$26.57K derived: sum of 2 quarters · filed 2022-11-10 | $84.40K 10-Q · filed 2022-11-10 | $97.01K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | -$45.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $65.15K 10-Q · filed 2022-08-01 | $77.76K derived: sum of 3 quarters · filed 2022-08-01 | $119.74K derived: sum of 4 quarters · filed 2022-08-01 | |||
| 2021-03-31 | $110.97K 10-Q · filed 2022-05-13 | $123.58K derived: sum of 2 quarters · filed 2022-05-13 | $165.56K derived: sum of 3 quarters · filed 2022-05-13 | $132.19K derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $12.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $54.59K derived: sum of 2 quarters · filed 2022-03-28 | $21.23K derived: sum of 3 quarters · filed 2022-03-28 | $72.53K 10-K · filed 2022-03-28 | |||
| 2020-09-30 | $41.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $8.61K derived: sum of 2 quarters · filed 2021-11-10 | $59.91K 10-Q · filed 2021-11-10 | $52.32K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$33.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $17.93K 10-Q · filed 2021-08-13 | $10.34K derived: sum of 3 quarters · filed 2021-08-13 | $45.28K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $51.30K 10-Q · filed 2021-05-17 | $43.70K derived: sum of 2 quarters · filed 2021-05-17 | $78.64K derived: sum of 3 quarters · filed 2021-05-17 | $60.51K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$7.59K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $27.35K derived: sum of 2 quarters · filed 2021-05-17 | $9.21K derived: sum of 3 quarters · filed 2021-05-17 | $29.23K 10-K/A · filed 2021-05-17 | |||
| 2019-09-30 | $34.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $16.81K derived: sum of 2 quarters · filed 2020-11-05 | $36.83K 10-Q · filed 2020-11-05 | $33.72K derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-30 | -$18.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.89K 10-Q · filed 2020-08-14 | -$1.22K derived: sum of 3 quarters · filed 2020-08-14 | -$17.61K derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | $20.02K 10-Q · filed 2020-05-12 | $16.92K derived: sum of 2 quarters · filed 2020-05-12 | $527.00 derived: sum of 3 quarters · filed 2020-05-12 | -$26.69K derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | -$3.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$19.49K derived: sum of 2 quarters · filed 2020-03-20 | -$46.71K derived: sum of 3 quarters · filed 2020-03-20 | -$12.71K 10-K · filed 2020-03-20 | |||
| 2018-09-30 | -$16.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$43.61K derived: sum of 2 quarters · filed 2019-11-13 | -$9.61K 10-Q · filed 2019-11-13 | -$1.66K derived: sum of 4 quarters · filed 2019-11-13 | |||
| 2018-06-30 | -$27.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $6.78K 10-Q · filed 2019-08-13 | $14.73K derived: sum of 3 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $34.00K 10-Q · filed 2019-05-14 | $41.95K derived: sum of 2 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $7.95K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-04 | -$14.76K 10-K · filed 2019-04-04 | |||||
| 2017-09-30 | -$22.70K 10-Q · filed 2018-11-14 | ||||||
| 2013-12-31 | -$7.88K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$11.52K derived: sum of 2 quarters · filed 2014-03-31 | -$17.76K 10-K · filed 2014-03-31 | ||||
| 2013-09-30 | -$3.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$9.88K 10-Q · filed 2013-11-14 | $11.59K 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | -$6.24K 10-Q · filed 2013-08-08 | $15.23K 10-Q · filed 2013-08-08 | |||||
| 2012-12-31 | $7.19K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $15.21K derived: sum of 2 quarters · filed 2014-03-31 | $17.97K 10-K · filed 2014-03-31 | ||||
| 2012-09-30 | $8.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $10.78K 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | $2.77K 10-Q · filed 2013-08-08 | ||||||
| 2011-12-31 | $3.50K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |